Robert Hamilton Pierce - Feb 15, 2022 Form 4/A - Amendment Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Chief R&D Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
SNSE
Transactions as of
Feb 15, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
9/1/2022, 04:57 PM
Date Of Original Report
Feb 17, 2022
Previous filing
Aug 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SNSE Common Stock 94.5K Feb 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 17, 2022, the reporting person filed a Form 4 which inadvertently reported an incorrect number of shares owned. This amendment is filed solely to correct the number of shares owned.